# Accurate Point of Care Liver Disease Diagnostics (Phase 2)

> **NCT07518784** · — · RECRUITING · sponsor: **University of California, San Diego** · enrollment: 26 (estimated)

## Conditions studied

- MASLD
- MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
- NAFLD
- NAFLD (Nonalcoholic Fatty Liver Disease)

## Interventions

- **DIAGNOSTIC_TEST:** LiverScope® exam
- **DIAGNOSTIC_TEST:** MR exam
- **DIAGNOSTIC_TEST:** Blood draw
- **OTHER:** Body measurements
- **OTHER:** Questionnaire

## Key facts

- **NCT ID:** NCT07518784
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-08
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2026-04-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07518784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07518784, "Accurate Point of Care Liver Disease Diagnostics (Phase 2)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07518784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*